Nanobiosensors for procalcitonin (PCT) analysis
Ahmad Mobed,Mohammad Darvishi,Amir Tahavvori,Iraj Alipourfard,Fereshteh Kohansal,Farhood Ghazi,Vahid Alivirdiloo
DOI: https://doi.org/10.1002/jcla.25006
IF: 3.124
2024-01-26
Journal of Clinical Laboratory Analysis
Abstract:Nanobiosensors for procalcitonin (PCT) analysis. Background Procalcitonin (PCT) is a critical biomarker that is released in response to bacterial infections and can be used to differentiate the pathogenesis of the infectious process. Objective In this article, we provide an overview of recent advances in PCT biosensors, highlighting different approaches for biosensor construction, different immobilization methods, advantages and roles of different matrices used, analytical performance, and PCT biosensor construction. Also, we will explain PCT biosensors sensible limits of detection (LOD), linearity, and other analytical characteristics. Future prospects for the development of better PCT biosensor systems are also discussed. Methods Traditional methods such as capillary electrophoresis, high‐performance liquid chromatography, and mass spectrometry are effective in analyzing PCT in the medical field, but they are complicated, time‐consuming sample preparation, and require expensive equipment and skilled personnel. Results In the past decades, PCT biosensors have emerged as simple, fast, and sensitive tools for PCT analysis in various fields, especially medical fields. Conclusion These biosensors have the potential to accompany or replace traditional analytical methods by simplifying or reducing sample preparation and making field testing easier and faster, while significantly reducing the cost per analysis.
medical laboratory technology